Replies to post #242384 on Innovation Pharmaceuticals Inc (IPIX)

[DaubersUP]

Private company. Details on data skeptical. IV based.

[wsbc]

W/o diving deep into the DD and numbers behind science, if memory serves, our mechanism of delivery is easier (wasn't their product IV-based?), and I thought we posted better initial numbers, but please don't quote me.

My concern is: WTF has been going ON with IPIX for a year almost now, concerning this financial situation. Other companies are FUNDED. We're sitting around waiting for... what? We don't even have results for the P trial from LAST DECEMBER. Is this a joke? Even if you 'couldn't imagine unforeseen costs related to getting the results from the CRO', are you kidding me that you're pinching things SO close that you can't even keep the lights on and are now laying people off of your already tiny company, can't get the results of your trial that has blockbuster potential, and now have possibly even veered-away from what you declared as a 'signed-term-sheet' in a 10-K... and for what? Because you aren't running the business by grounding yourselves with 'sound business principles'?

I GET IPIX being a 'pre-revenue-bio' company. But the time is NOW to execute and to realize a revenue stream from one of the products that they've been developing within their 'value-based pipeline'. Shit or get off the pot... literally, that's what its come down to. Were they honestly thinking that they were really THAT close to a deal that they could walk away from Aspire, torch the milestones where first it was announced that they were on track to meet... and now they're announcing that none will be met?

The drums are beating in the background and getting louder. Galera has BTD designation for their OM compound. I appreciate that there's a dire need for a solution here, and the market can support many options, but let's GET something TO MARKET, LEO. This is beyond absurd. IPIX has SO much potential, but we're seeing VERY little action related to actually monetizing products and pushing things out the door. Nothing comes from making excuses. Actions are everything. Fluffy and nonsensical PR's are exactly that. Let's see some real action for a change. Eh?

Looks like we have some serious competition on OM. There investor base is impressive as is their execution.
Sounds like there is a lot of private equity out there to fund small bio, climate seems right to raise capital.
Did their OM prevent ? Is our's superior?